scholarly journals Rheumatic Diseases Presenting with Guillain-Barré Syndrome: Sjögren’s Syndrome and Systemic Lupus Erythematosus

2020 ◽  
Vol 21 (1) ◽  
pp. 9-11
Author(s):  
Ebru Aytekin ◽  
Hüdanur Coşkun ◽  
Yasemin Pekin Doğan ◽  
Burak Tayyip Dede ◽  
Özer Burnaz ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Rheumatic Diseases ◽  
Lupus Erythematosus ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Guillain Barre Syndrome ◽  
Systemic Lupus ◽  
Guillain Barré Syndrome ◽  
Guillain Barré ◽  
Sjögren‘S Syndrome

scholarly journals Doença Intersticial Pulmonar Grave e Mania Induzida por Corticosteróides em Doente com Lúpus Eritematoso Sistémico e Síndrome de Sjögren Secundária

2017 ◽  
Vol 30 (3) ◽  
pp. 246 ◽  
Author(s):  
Sofia Silvério Serra ◽  
Teresa Pedrosa ◽  
Sandra Falcão ◽  
Jaime Cunha Branco
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Sjögren’S Syndrome ◽  
Lupus Erythematosus ◽  
Sjögren's Syndrome ◽  
Manic Episode ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Neurological Involvement ◽  
Systemic Lupus ◽  
Sjögren‘S Syndrome

Interstitial lung disease occurs in up to 25% of patients with Sjögren’s syndrome and 2% - 8 % of patients with systemic lupus erythematosus. Corticosteroid therapy remains the main treatment for systemic lupus erythematosus. However, it can be associated with several neuropsychiatric disorders especially with prednisolone at a dose of more than 40 mg/day. We present the case of a 51-year-old patient with systemic lupus erythematosus and secondary Sjögren’s syndrome with severe pulmonary involvement four years after the diagnosis. Chest computed tomography revealed neofibrosis and ground glass appearance pattern. After increasing the dose of prednisolone to 60 mg/day, the patient presented a manic episode. There was need of hospitalization and the situation was considered to be secondary to corticosteroids at high doses. Central neurological involvement by organic disease was excluded.We introduced monthly perfusion of cyclophosphamide for six months and later started mycophenolate mofetil 2 g/day, reducing prednisolone to 10 mg/day and maintaining hydroxychloroquine 400 mg/day, with control of disease activity.

scholarly journals Brief Report: Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome

2017 ◽  
Vol 69 (11) ◽  
pp. 2187-2192 ◽  
Author(s):  
Rohan Sharma ◽  
Valerie M. Harris ◽  
Joshua Cavett ◽  
Biji T. Kurien ◽  
Ke Liu ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Sjögren’S Syndrome ◽  
X Chromosome ◽  
Lupus Erythematosus ◽  
Sjögren's Syndrome ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Chromosome Abnormalities ◽  
Systemic Lupus ◽  
Sjögren‘S Syndrome
Sign in / Sign up

Export Citation Format

Share Document